Cannabis Habit More Likely with Genetic Predisposition to Schizophrenia
the Psychiatry Advisor take:
Previous research has establish an association between cannabis use and schizophrenia, but it is unknown whether cannabis use increases psychosis risk, or whether the same genes that predispose individuals to psychosis predispose individuals to cannabis use.
To better understand this relationship, Robert Power, of the MRC Social, Genetic & Developmental Psychiatry Centre, in the Institute of Psychiatry at King's College London, and colleagues analyzed data from a sample 2,082 healthy individuals, about half of whom had used cannabis.
The researchers assigned participants to a genetic risk profile based on the number of genes associated with schizophrenia that they carried, and then looked at their likelihood of cannabis use.
Participants whose genetic risk profile predisposed them to schizophrenia were more likely to use cannabis (P=2.6 × 10−4), and to use it more (P=3.0 × 10−3), than those who did not carry schizophrenia risk genes, data indicated.
"[T]hese findings suggest that part of the association between schizophrenia and cannabis is due to a shared genetic aetiology. This form of gene–environment correlation is an important consideration when calculating the impact of environmental risk factors, including cannabis use," the researchers reported in Molecular Psychology.
The study findings are particularly important in the context of the debate about legalizing marijuana.
"Certain environmental risks, such as cannabis use, may be more likely given an individual's innate behavior and personality, itself influenced by their genetic make-up. This is an important finding to consider when calculating the economic and health impact of cannabis," they wrote.
Individuals who carry schizophrenia risk genes were more likely to use cannabis and to use it more, than those without the genes.
Cannabis Habit More Likely with Schizophrenia Gene
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Evzio Authorized Generic Soon to Be Available
- AMA Survey Collects Advice for Physicians Approaching Retirement
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Cognition, Depression, and Limited Functioning Linked in Middle Age
- Coping With Challenges When Working the Holidays
- Lithium Preferred Method of Maintenance Monotherapy in Older Adults With Bipolar Disorder
- Hypobetalipoproteinemia Associated With Aggression and Schizophrenia
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information